Search for: "PFIZER V TEVA PHARMA"
Results 1 - 20
of 143
Sort by Relevance
|
Sort by Date
5 Apr 2023, 5:18 am
A similar situation arose a few years in Pfizer v Roche [2019] EWHC 1520 (Pat). [read post]
14 Feb 2023, 12:29 pm
</span> </p> <p> <span style="display: initial;"> <br/> </span> </p> <p> <span style="display: initial;"> <span style="display: initial;"> Some well-known patent infringement </span> </span> <a href="https://www.greyb.com/largest-patent-infringement-awards/" target="_blank"… [read post]
8 May 2020, 6:57 pm
” Pfizer, Inc. v. [read post]
17 Mar 2020, 1:32 pm
Twelve Lots of CHANTIX® (Varenicline) Tablets have been recalled by Pfizer due to N-Nitroso Varenicline content above ADI level. [read post]
27 Aug 2017, 10:01 pm
FTC v. [read post]
27 Aug 2017, 10:01 pm
FTC v. [read post]
22 Mar 2016, 4:00 am
Although manufacturers are still fragmented, consolidations continue based on “better rationales” (given the standard merger rewards may not necessarily exist): including Pfizer/Hospira, Teva/Actavis and focused start-ups. [read post]
18 Jul 2014, 11:55 am
Teva Pharmaceuticals USA, Inc., 2010 WL 2640170, at *2 (W.D. [read post]
22 Apr 2014, 11:51 am
Natco Pharma (Fed. [read post]
13 Apr 2014, 8:59 am
Teva Canada Ltd. v. [read post]
28 Mar 2014, 5:33 pm
MagSil Corp. v. [read post]
10 Nov 2013, 6:37 am
Pravin then alluded to decisions involving patents owned by Pfizer and Merck, in which the outcome was rather better for the proprietary pharma sector. [read post]
10 Mar 2013, 9:59 pm
Searle LLC et al. v. [read post]
18 Feb 2013, 12:46 am
Madhulika reported that the Patent Office revoked Pfizer’s patent on Sunitib- an exorbitantly priced drug. [read post]
13 Feb 2013, 11:49 pm
The invalidation was pursuant to a law suit bought by BMS (the patentee) against Teva, a leading Israeli generic company. [read post]
1 Feb 2013, 9:42 am
Pfizer, Inc., 877 F. [read post]
18 Jan 2013, 2:06 pm
We already did that in connection with the original decision in Conte v. [read post]
27 Dec 2012, 3:47 pm
Schwarz Pharma, Inc., ___ Fed. [read post]
6 Dec 2011, 11:22 pm
Highlights this week included: Federal Circuit affirms invalidity of Teva’s patent on Rosuvastatin formulation: Teva v AstraZeneca (Orange Book Blog) (Patently-O) (IPBiz) Pfizer’s Lipitor: A new model for delaying the effects of patent expiration [...] [read post]
2 Nov 2011, 2:00 am
Novartis Vaccines & Diagnostics (Pharma Patents) US: CAFC Affirms district court de novo review in section 146 action: Streck v. [read post]
